Cite
HARVARD Citation
Lee, S. et al. (n.d.). Certolizumab Pegol Induces Clinical Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: An Open‐Label Study. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, S. et al. (n.d.). Certolizumab Pegol Induces Clinical Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: An Open‐Label Study. American journal of gastroenterology. p. . [Online].